Literature DB >> 6223133

Generalized lymphadenopathy and T cell abnormalities in hemophilia A.

J C Gill, J E Menitove, D Wheeler, R H Aster, R R Montgomery.   

Abstract

Two patients with hemophilia A had generalized lymphadenopathy, lymphopenia, elevated IgG values, depressed T4 (helper) lymphocytes, elevated T8 (suppressor) lymphocytes, and abnormally low T4/T8 ratios. One of the patients, who also had hepatosplenomegaly, underwent cervical lymph node biopsy; the node contained 43% T8-lymphocytes, a marked elevation over the small fraction of T8 cells usually found in lymph nodes. These patients may have a form of the acquired immune deficiency syndrome described in male homosexuals, Haitians, intravenous drug abusers, and recently, in patients with hemophilia. We studied T cell phenotypes in 43 patients with hemophilia. Fourteen of 28 patients given commercial factor VIII concentrates had abnormal T4/T8 ratios; none of nine patients who used cryoprecipitate had abnormal values. T4 helper cells were significantly lower, T8 suppressor cells significantly elevated, and T4/T8 ratios significantly lower in the lyophilized concentrate users and in patients with hemophilia as a total group. The type of therapeutic factor VIII replacement may alter the risk of developing T4/T8 abnormalities or AIDS.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6223133     DOI: 10.1016/s0022-3476(83)80768-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Gene therapy for haemophilia.

Authors:  Akshay Sharma; Manu Easow Mathew; Vasumathi Sriganesh; Ulrike M Reiss
Journal:  Cochrane Database Syst Rev       Date:  2020-04-28

2.  Persistent lymphadenopathy in patients at risk of contracting acquired immune deficiency syndrome.

Authors:  J P Clauvel; J L Couderc; G Tricot; C Rabian; M F D'Agay; J C Brouet
Journal:  Eur J Clin Microbiol       Date:  1984-02       Impact factor: 3.267

Review 3.  Current options and new developments in the treatment of haemophilia.

Authors:  Trisha Wong; Michael Recht
Journal:  Drugs       Date:  2011-02-12       Impact factor: 9.546

Review 4.  Gene therapy for haemophilia.

Authors:  Akshay Sharma; Manu Easow Mathew; Vasumathi Sriganesh; Ulrike M Reiss
Journal:  Cochrane Database Syst Rev       Date:  2016-12-20

Review 5.  Pathobiology of HIV/SIV-associated changes in secondary lymphoid tissues.

Authors:  Jacob D Estes
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

Review 6.  Current state of portosystemic shunt surgery.

Authors:  Martin Wolff; Andreas Hirner
Journal:  Langenbecks Arch Surg       Date:  2003-03-29       Impact factor: 3.445

7.  Immunological changes in beta-thalassemia major patients positive for HTLV-III antibodies.

Authors:  M A Romeo; G Russo Mancuso; L Mauro; A Sciotto; M A Romeo; F Di Gregorio; G Giammanco; G Schiliro
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

8.  Lymphocytes of haemophilia patients treated with clotting factor concentrates display activation-linked cell-surface antigens.

Authors:  U Köller; O Majdic; K Liszka; H Stockinger; I Pabinger-Fasching; K Lechner; W Knapp
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

9.  Human immunodeficiency virus infection in multi-transfused patients with thalassaemia major.

Authors:  P E Manconi; C Dessí; G Sanna; F Argiolu; P Pellegrini-Bettoli; R Piro; O Masotti; A Cao
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.